SOURCE: Bio Supply Management Alliance (BSMA)

BSMA

June 23, 2016 03:00 ET

BSMA Goes International -- 1st European Life Sciences Supply Chain Community Conference -- Held in Brussels, May 19, 2016

CALABASAS, CA--(Marketwired - June 23, 2016) - The inaugural Conference of the Bio Supply Chain Management Alliance (BSMA) -- Europe brought together over 180 supply chain management executives from 19 countries on the 19th of May 2016 at the Dolce la Hulpe in Brussels, Belgium. Themed "Enhancing Collaboration across Life Sciences Supply Chain", nearly 120 companies participated with Bayer, Baxalta, Baxter, UCB, GSK Vaccines, GSK Cell & Gene, Biomarin, Mölnlycke, Illumina, J&J, MSD, and Thermofisher being some of the majors. True to its mission, BSMA uniquely differentiated itself from other industry associations with the presence of stakeholders end-to-end, such as manufacturers, suppliers, wholesalers, CMO's, CRO's, logistics service providers, hospitals, international organizations, regulators, management consultants and academia.

Devendra Mishra, Executive Director and Founder of BSMA, welcomed the participants with the history of the establishment of BSMA nine years ago in San Francisco, the birthplace of biotech. "The mission of BSMA is to promote collaboration among supply chain professionals to build an effective and efficient supply chain for the Life Sciences industry by developing, advancing, and disseminating best practices, knowledge and research. The establishment of BSMA Europe is a major step toward building a global community of like-minded professionals," he said.

Franck Toussaint, Executive Director of BSMA Europe and Managing Director of Biolog Europe, reaffirmed, "We are determined to serve the global nature of our biopharma industry where ensuring the integrity, quality and responsiveness to delivering patient care is paramount. Our perspective of agile supply chain management will focus on technology, best processes and human resources to advance patient care, drug development and professional careers."

The conference provided extraordinary insights and solutions to problems faced by the biopharma industry from the supply chain perspective. Some of the subjects addressed were:

  • The Journey to Build a System for Managing Clinical Supplies
  • Transforming Logistics Oversight through the Internet of Things
  • Serialization challenges / Rethinking Bio-manufacturing
  • The evolution of Biosafety Regulation, IDMP Regulation, GDP, IATA CEIV
  • M&A Impact on Supply Chain: A Real Case Study
  • Collaboration Across the supply chain : Needs and Examples of Success Cases
  • Transportation -- Shift Ocean-air, New Ways to Use Multimodal Transport
  • 3D Printing in Healthcare Market
  • Collaboration initiatives in the Life Sciences Supply Chain Industries and Testimonials
  • M&A impact on Supply Chain
  • GMP Requirements for ATMP Production
  • Get Ready for Serialization -- Easily and Effectively
  • Transforming Logistics Oversight through the Internet of Things
  • The evolution of Biosafety Regulation and Impact on Supply Chain
  • The Airport, is it Really a Controlled Environment for Bio product?
  • Oceanic Transportation -- from Air Logistics to Sea-Based Solutions?
  • Trends and Evolution for the Transport Between China and Europe -- The Silk Road
  • Next Generation Blending Processes for Efficient and Green Pharmaceutical Manufacturing

Industry panels of eminent subject matter experts were conducted for Clinical Supply Chain, Cold Chain, Biotech Supply Chain Management and Talent/Career Development. Through interactive panel discussions, debates and presentations, attendees benefitted from others' experience in optimizing the supply chain. There was a wide consensus that the opportunity to identify unmet needs was significant and BSMA Europe was providing a platform for collaboration.

Dr. Joseph Augustine Martial, Chairman of the Board of Directors, GIGA University of Liege, and a biochemist who participated in the discovery of the growth hormone gene as an adjunct assistant professor at UCSF (1977-80), delivered an inspirational keynote address to wrap up the conference. He proclaimed, "BSMA Europe managed in partnership with BSMA USA is not only interesting; it is of crucial importance for the solid development of the New Life Science industry worldwide. We are witnessing the Second Revolution in Life Science with Genome Editing where the availability of programmable nucleuses and relatively easy tools to perform high activity with high specificity and applicability in a wide range of cells is producing breakthroughs in research. Genome Editing allows targeted deletion, disruption, correction and integration in any genome for unlimited applications in microbial biotech, plant breeding, animal breeding and human health. The technology is advancing so rapidly that experiments in human embryos have already started in China a while America and Europe are still forming committees." He urged the audience to act as, "The supply chain of the biotech industry will continue to be put under pressure to adopt these spectacular new developments. Success will only be achieved if you, the field specialists, regroup forces and work together, not only in one country but worldwide. It is not an option. It is an obligation. The setup of BSMA Europe goes in the right direction."

The BSMA Europe award for SCM Excellence was given to GSK, which was received by Pascal Reyntjens, Director, Vaccines Distribution and Cold Chain, GSK.

ABOUT BSMA -- The Bio Supply Management Alliance, which organizes the Conference, was born of the need to create a worldwide community of operations and supply chain management leaders and professionals in the biotech, biopharma, and biomedical device industries. Based in the San Francisco Bay Area, home to more than 400 bio firms, the Alliance provides a forum for collaboration, learning and best practice sharing of practitioners, executives and thought leaders in these uniquely demanding industries.

Because life depends on us™, the Bio Supply Management Alliance supports continuous learning and improvement of bio supply management professionals.

ABOUT BIOLOG EUROPE -- Biolog Europe is a not for profit life sciences supply chain dedicated organization whose helping the industry on various topics such as new regulations analysis, risk management methods, collaboration in management of flows and by conducting dedicated workshops and initiatives (e.g., stem cells supply chain, hospitals supply chain). Based in Belgium, Europe, the organization has developed an excellence center in the themes around Life Sciences supply chain.

Building Supply Chain Excellence End to End

Image Available: http://www.marketwire.com/library/MwGo/2016/6/21/11G103718/Images/SAM_2331-200-4ee20103d160b0e4a6747358413f2a98.jpg
Image Available: http://www.marketwire.com/library/MwGo/2016/6/21/11G103718/Images/SAM_2324-200-76887d4fdecd8795849fb52fcd631bb7.jpg
Image Available: http://www.marketwire.com/library/MwGo/2016/6/21/11G103718/Images/SAM_3039-200-c2147039284a99b59ffb41c82a0e5f59.jpg
Image Available: http://www.marketwire.com/library/MwGo/2016/6/21/11G103718/Images/SAM_3084-200-f5543934a3dfb379aac4a8f8c453189b.jpg

Contact Information